Recurrent Verrucous Carcinoma of the Larynx Completed Phase 2 Trials for Ispinesib (DB06188)

IndicationStatusPhase
DBCOND0029506 (Recurrent Verrucous Carcinoma of the Larynx)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00095628SB-715992 in Treating Patients With Recurrent or Metastatic Head and Neck CancerTreatment